Showing results (151-160 of 165) with videos related to
Sort By:
Pageof 17
Plos Medicine|May 8, 2019
Behavioural intervention for weight loss maintenance versus standard weight advice in adults with obesity: A randomised controlled trial in the UK (NULevel Trial)Falko F Sniehotta, Elizabeth H Evans, Kirby Sainsbury, et al.Plos One|May 7, 2025
Food, Pregnancy & Me: Exploring food insecurity in pregnancy in the UK to inform future public health intervention needs-A mixed-methods study protocolKiya L Hurley, Kate Jolly, Heather Brown, et al.Plos Genetics|March 4, 2024
Divergent role of Mitochondrial Amidoxime Reducing Component 1 (MARC1) in human and mouseEriks Smagris, Lisa M Shihanian, Ivory J Mintah, et al.Redox Biology|October 6, 2024
A randomized trial of pharmacological ascorbate, gemcitabine, and nab-paclitaxel for metastatic pancreatic cancerKellie L Bodeker, Brian J Smith, Daniel J Berg, et al.Autoimmunity|March 21, 2009
An antibody to IP-10 is a potent antagonist of cell migration in vitro and in vivo and does not affect disease in several animal models of inflammationFergus R Byrne, Aaron Winters, David Brankow, et al.Trials|September 24, 2015
The NULevel trial of a scalable, technology-assisted weight loss maintenance intervention for obese adults after clinically significant weight loss: study protocol for a randomised controlled trialElizabeth H Evans, Vera Araújo-Soares, Ashley Adamson, et al.Frontiers in Public Health|July 10, 2023
Natural experiments for the evaluation of place-based public health interventions: a methodology scoping reviewPatricia N Albers, Chiara Rinaldi, Heather Brown, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 28, 2020
Establishment of a Pig Influenza Challenge Model for Evaluation of Monoclonal Antibody Delivery PlatformsAdam McNee, Trevor R F Smith, Barbara Holzer, et al.Plos One|January 13, 2016
A Novel Triazolopyridine-Based Spleen Tyrosine Kinase Inhibitor That Arrests Joint InflammationGregory D Ferguson, Mercedes Delgado, Veronique Plantevin-Krenitsky, et al.Nature Communications|May 14, 2021
Tissue-specific activation of gene expression by the Synergistic Activation Mediator (SAM) CRISPRa system in miceCharleen Hunt, Suzanne A Hartford, Derek White, et al.Pageof 17